Information Provided By: 
Fly News Breaks for March 2, 2020
MTBC
Mar 2, 2020 | 07:07 EDT
H.C. Wainwright analyst Kevin Dede downgraded MTBC to Neutral from Buy with an unchanged price target of $6. As much as the new CareCloud deal offers, MTBC's nearer-term risk/reward scenario is unfavorable, Dede tells investors in a research note. The analyst is "uneasy" about the next few quarterly reports and suggests investors "pull their chips from the table."
News For MTBC From the Last 2 Days
There are no results for your query MTBC
